Monitoring Gesetzessammlung

Gesetze und Verordnungen US - USC Title 21: Food and Drugs alphabetisch

A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z
0 1 2 3 4 5 6 7 8 9
§ 379j–21 - Authority to assess and use generic new animal drug fees
21 USC 379j–21
§ 379j–22 - Reauthorization; reporting requirements
21 USC 379j–22
§ 379j–31 - Authority to collect and use fees
21 USC 379j–31
§ 379j–41 - Definitions
21 USC 379j–41
§ 379j–42 - Authority to assess and use human generic drug fees
21 USC 379j–42
§ 379j–43 - Reauthorization; reporting requirements
21 USC 379j–43
§ 379j–51 - Definitions
21 USC 379j–51
§ 379j–52 - Authority to assess and use biosimilar biological product fees
21 USC 379j–52
§ 379j–53 - Reauthorization; reporting requirements
21 USC 379j–53
§ 379j–61 - Definitions
21 USC 379j–61
§ 379j–62 - Authority to assess and use outsourcing facility fees
21 USC 379j–62
§ 379j–71 - Definitions
21 USC 379j–71
§ 379j–72 - Authority to assess and use OTC monograph fees
21 USC 379j–72
§ 379j–73 - Reauthorization; reporting requirements
21 USC 379j–73
§ 379k - Information system
21 USC 379k
§ 379k–1 - Electronic format for submissions
21 USC 379k–1
§ 379l - Education
21 USC 379l
§ 379o - Environmental impact
21 USC 379o
§ 379r - National uniformity for nonprescription drugs
21 USC 379r
§ 379s - Preemption for labeling or packaging of cosmetics
21 USC 379s
Verwendung von Cookies.

Durch die Nutzung dieser Website akzeptieren Sie automatisch, dass wir Cookies verwenden. Cookie-Richtlinie

Akzeptieren
Markierungen
Leseansicht